Merck (MRK) Tops Q4 EPS by 4c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $125.78 +0.44%
EPS Growth %: +41.4%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +41.4%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $0.98, $0.04 better than the analyst estimate of $0.94. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.49 billion.
GUIDANCE:
Merck sees FY2018 EPS of $4.08-$4.23, versus the consensus of $4.11 on revenue of $41.2 to $42.7 billion vs $41.07 expected.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14
- Parke Bancorp (PKBK) Reports Q1 EPS of $0.51
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
